When researchers at the University of Maryland School of Medicine and the Center for Substance Abuse Research (CESAR) set up a study in two Maryland emergency departments designed to identify overdose patients with synthetic cannabinoids in their system, they expected to find just that. Instead, out of 175 urine samples, only one tested positive.